Amana Mutual Funds Trust’s Top Healthcare Stocks: NVS, JNJ, LLY, HUM, AMGN, GSK, PFE

Wall St. Watchdog reveals information regarding Amana Mutual Funds Trust’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 34 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $437.386 million.

  • Novartis Ag (NYSE:NVS): On 06/30/2011, Amana Mutual Funds Trust reported holding 1,176,003 shares with a market value of $71,865,544. This comprised 2.13% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 1,176,003 shares with a market value of $65,585,688. This comprised 2.45% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Amana Mutual Funds Trust reported holding 942,446 shares with a market value of $62,691,505. This comprised 1.86% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 941,446 shares with a market value of $59,960,694. This comprised 2.24% of the total portfolio. The net change in shares for this position over the two quarters is -1,000. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Amana Mutual Funds Trust reported holding 1,358,300 shares with a market value of $50,976,997. This comprised 1.51% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 1,358,800 shares with a market value of $50,234,838. This comprised 1.88% of the total portfolio. The net change in shares for this position over the two quarters is 500. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, Amana Mutual Funds Trust reported holding 655,574 shares with a market value of $52,799,931. This comprised 1.56% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 656,162 shares with a market value of $47,722,664. This comprised 1.78% of the total portfolio. The net change in shares for this position over the two quarters is 588. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Amana Mutual Funds Trust reported holding 605,944 shares with a market value of $35,356,831. This comprised 1.05% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 605,944 shares with a market value of $33,302,682. This comprised 1.24% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Amana Mutual Funds Trust reported holding 811,513 shares with a market value of $23,501,416. This comprised 0.7% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 810,513 shares with a market value of $25,433,897. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is -1,000. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Amana Mutual Funds Trust reported holding 564,650 shares with a market value of $24,223,486. This comprised 0.72% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 563,650 shares with a market value of $23,273,109. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is -1,000. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
  • Novo Nordisk A/s (NYSE:NVO): On 06/30/2011, Amana Mutual Funds Trust reported holding 225,839 shares with a market value of $28,293,110. This comprised 0.84% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 225,839 shares with a market value of $22,475,497. This comprised 0.84% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Amana Mutual Funds Trust reported holding 1,240,183 shares with a market value of $25,547,770. This comprised 0.76% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 1,241,405 shares with a market value of $21,948,041. This comprised 0.82% of the total portfolio. The net change in shares for this position over the two quarters is 1,222. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Astrazeneca Plc (NYSE:AZN): On 06/30/2011, Amana Mutual Funds Trust reported holding 450,000 shares with a market value of $22,531,500. This comprised 0.67% of the total portfolio. On 09/30/2011, Amana Mutual Funds Trust reported holding 450,000 shares with a market value of $19,962,000. This comprised 0.75% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.

(Note: Data regarding Amana Mutual Funds Trust’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>